Rabeprl 20 mg Injection 1's

Rabeprl 20 mg Injection 1's is used to treat gastric/duodenal ulcers, gastro-oesophageal reflux disease (GERD), heartburn, prevention of acid-aspiration, stress-induced mucosal injury, and Zollinger-Ellison syndrome.

Rabeprl 20 mg Injection 1's contains 'Rabeprazole' that works by blocking the action of the enzyme known as gastric proton pump, which is responsible for the production of acid. This helps in reducing the amount of acid produced, heals the ulcers and prevents the formation of new ulcers.

In some cases, you may experience certain common side effects, such as pain at the site of injection, diarrhoea, dizziness, dry mouth, headache, and abdominal pain. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

On long-term treatment, Rabeprl 20 mg Injection 1's may cause low magnesium levels and vitamin B12 levels and increase the risk of bone fractures. Consult your doctor if you are pregnant or breastfeeding. Rabeprl 20 mg Injection 1's may cause dizziness, so drive only if you are alert. Rabeprl 20 mg Injection 1's is not recommended for children as safety has not been established. Avoid consuming alcohol along with Rabeprl 20 mg Injection 1's as it could lead to increased drowsiness and can elevate the production of stomach acid.

Rabeprl 20 mg Injection 1's is used in the treatment of Gastro-oesophageal reflux disease (GERD), Duodenal/Gastric ulcers, and Zollinger-Ellison syndrome. The detailed uses of Rabeprl 20 mg Injection 1's are as follows:

• Treatment of Gastro-oesophageal Reflux Disease (GERD): Rabeprl 20 mg Injection 1's helps to manage symptoms of GERD, such as heartburn and acid reflux, by reducing stomach acid production.
• Relief from Duodenal/Gastric Ulcers: Rabeprl 20 mg Injection 1's helps to treat duodenal and gastric ulcers by reducing stomach acid, allowing the ulcers to heal.
• Management of Zollinger-Ellison Syndrome: Rabeprl 20 mg Injection 1's manages excessive acid production in the stomach, helping to alleviate symptoms and prevent complications associated with the condition.

• Follow your doctor’s instructions on the dosage and timing of this medication to ensure safe and effective use.
• Rabeprl 20 mg Injection 1's will be administered by the doctor or healthcare professional.
• Do not self-administer.

Rabeprl 20 mg Injection 1's belongs to a group of antiulcer medicines called proton pump inhibitors. Rabeprl 20 mg Injection 1's is used to treat gastric ulcers, duodenal ulcers, gastro-oesophageal reflux disease (GERD), heartburn, prevention of acid-aspiration, stress-induced mucosal injury, and Zollinger-Ellison syndrome. Rabeprl 20 mg Injection 1's works by blocking the action of the enzyme known as gastric proton pump, which is responsible for the production of acid. This helps in reducing the amount of acid produced, heals the ulcers and prevents the formation of new ulcers.

Do not take Rabeprl 20 mg Injection 1's if you are allergic to any of its contents. Inform your doctor if you have a stomach tumour, liver disease, or if you are due to have Chromogranin A blood test. On long-term treatment, Rabeprl 20 mg Injection 1's may cause low magnesium levels, vitamin B12 levels, and increase the risk of bone fractures; the doctor may advise regular tests for monitoring your condition. Consult your doctor before starting Rabeprl 20 mg Injection 1's if you are pregnant or breastfeeding. Rabeprl 20 mg Injection 1's may cause dizziness, so drive only if you are alert. Rabeprl 20 mg Injection 1's is not recommended for children as safety has not been established. Avoid consuming alcohol along with Rabeprl 20 mg Injection 1's as it could lead to increased drowsiness and can elevate the production of stomach acid. Keep your doctor informed about your health condition and medicines to rule out any side-effects.